Streetbeat News

Products Services

MATIC

Donald Trump's fourth NFT collection, 'Series 4: The America First Collection,' generated over $2 million in sales within a day on the Polygon network. The collection, priced at $99 per NFT, represents only 6% of its total potential supply. Unlike previous collections, these NFTs are not tradable until January 2025. Trump's engagement in the NFT space marks a shift from his earlier skepticism towards digital currencies.

Portfolio Pulse from Murtuza Merchant

August 29, 2024 | 11:54 am

AMZN

Amazon has secured regulatory permission to acquire land in New Zealand for Project Kuiper, its satellite internet initiative. The project aims to provide global broadband coverage with over 3,000 satellites, similar to Starlink. Amazon plans to launch satellites by 2024 and start customer tests in 2025. The company reported a 10% revenue growth in Q2, but missed analyst estimates. Amazon's stock has gained 27% in the last year, with a 30.6% upside expected by 2025.

Portfolio Pulse from Anusuya Lahiri

August 29, 2024 | 11:54 am

BCDA

BioCardia's shares rise as the FDA approves its Morph DNA Steerable Introducer product family for market release.

Portfolio Pulse from Benzinga Newsdesk

August 29, 2024 | 11:53 am

MSTR

The digital assets sector has rebounded from the FTX collapse, with MicroStrategy outperforming Bitcoin and Ethereum. The introduction of spot ETFs has driven institutional adoption, but challenges remain.

Portfolio Pulse from Murtuza Merchant

August 29, 2024 | 11:44 am

QDEL

QuidelOrtho has received FDA 510(k) clearance for its Vitros Syphilis Assay, which is used for detecting antibodies related to syphilis infection. This assay is now available globally where QuidelOrtho products are sold.

Portfolio Pulse from Benzinga Newsdesk

August 29, 2024 | 11:41 am

ADPT

Adaptive Biotechnologies has received IVDR certification for its clonoSEQ diagnostic test in the European Union, marking a significant regulatory milestone.

Portfolio Pulse from Benzinga Newsdesk

August 29, 2024 | 11:33 am

GANX

Gain Therapeutics announced positive topline results from its Phase 1 clinical trial of GT-02287, confirming that single and multiple doses were safe and well-tolerated across age groups.

Portfolio Pulse from Benzinga Newsdesk

August 29, 2024 | 11:32 am

AMD

BABA

MU

NVDA

China is investing over $6 billion in data centers in response to the US semiconductor embargo, which affects companies like Nvidia, AMD, and Micron. Despite the embargo, Nvidia's revenue remains strong, while Alibaba's AI ambitions are impacted.

Portfolio Pulse from Anusuya Lahiri

August 29, 2024 | 11:26 am

ECX

ECARX has partnered with MulticoreWare to optimize algorithms for intelligent driving solutions on multi-core heterogeneous compute platforms. This collaboration aims to enhance the performance of ECARX's advanced driving systems by integrating CPU, GPU, and DSP technologies.

Portfolio Pulse from Benzinga Newsdesk

August 29, 2024 | 11:24 am

SNDL

SNDL's stalking horse bid for Indiva's business and assets has been successful. The acquisition includes a facility in London, Ontario, and a portfolio of brands, enhancing SNDL's product offerings in the Canadian cannabis market. The transaction is expected to close in the fourth quarter.

Portfolio Pulse from Benzinga Newsdesk

August 29, 2024 | 11:22 am